BRADY CORP
For the period ended Jan 31, 2024. Filed Feb 22, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jan 31, 2024 · Filed Feb 22, 2024
BRC$80.00+0.1%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows
| Six months ended January 31, | ||
|---|---|---|
| 2024 | 2023 | |
| Operating activities: | ||
| Net income | $90,869 | $77,427 |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||
| Depreciation and amortization | 15,008 | 17,117 |
| Stock-based compensation expense | 5,263 | 4,381 |
| Deferred income taxes | (3,640) | (5,234) |
| Other | 947 | (908) |
| Changes in operating assets and liabilities: | ||
| Accounts receivable | (5,030) | 280 |
| Inventories | 10,078 | (1,287) |
| Prepaid expenses and other assets | (1,187) | (3,502) |
| Accounts payable and accrued liabilities | (9,754) | (29,156) |
| Income taxes | (4,203) | (1,734) |
| Net cash provided by operating activities | 98,351 | 57,384 |
| Investing activities: | ||
| Purchases of property, plant and equipment | (60,832) | (8,167) |
| Other | — | 11 |
| Net cash used in investing activities | (60,832) | (8,156) |
| Financing activities: | ||
| Payment of dividends | (22,694) | (22,793) |
| Proceeds from exercise of stock options | 5,366 | 2,688 |
| Payments for employee taxes withheld from stock-based awards | (2,362) | (1,509) |
| Purchase of treasury stock | (21,797) | (17,861) |
| Proceeds from borrowing on credit agreement | 69,145 | 71,036 |
| Repayment of borrowing on credit agreement | (70,771) | (88,755) |
| Other | 149 | 66 |
| Net cash used in financing activities | (42,964) | (57,128) |
| Effect of exchange rate changes on cash and cash equivalents | (2,227) | 2,041 |
| Net decrease in cash and cash equivalents | (7,672) | (5,859) |
| Cash and cash equivalents, beginning of period | 151,532 | 114,069 |
| Cash and cash equivalents, end of period | $143,860 | $108,210 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.